News
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
FDA announced efforts to streamline its drug importation process to help U.S. states and Native American tribes access ...
Emerson’s purpose-built industrial AI solutions are meant to enhance accessibility and reliability, enabling manufacturers to ...
Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to ...
Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development ...
Dave Wood, CEO at Experic, discusses how decades of expertise with advanced technologies helps pharmaceutical and biotech partners bring products to market faster.
Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...
The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...
ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized ...
The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...
According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results